albuterol + salmeterol

Albuterol + salmeterol is a hypothetical combination of two bronchodilator drugs, both classified as beta-2 adrenergic receptor agonists. Albuterol is a short-acting beta-2 agonist (SABA) that provides rapid relief from bronchospasm by relaxing airway smooth muscle, typically used as a rescue inhaler in asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta-2 agonist (LABA) that provides prolonged bronchodilation and is used for maintenance therapy in asthma and COPD. Both drugs act on the beta-2 adrenergic receptor but differ in onset and duration of action. This specific dual-drug combination does not appear to be commercially available or approved; instead, combinations with corticosteroids such as fluticasone/salmeterol are widely marketed[4][5][6][8]. The primary indication for each drug individually includes asthma and COPD.